Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).:
SEC Accession No. 0001104659-16-091552
Filing Date
2016-01-27
Accepted
2016-01-27 08:23:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 IRANNOTICE a16-1209_3irannotice.htm IRANNOTICE 8972
2 GRAPHIC g12093bgi001.jpg GRAPHIC 3113
  Complete submission text file 0001104659-16-091552.txt   14335
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: IRANNOTICE | Act: 34 | File No.: 001-15024 | Film No.: 161363040
SIC: 2834 Pharmaceutical Preparations